Real-time enrollment status for this temporal lobe epilepsy clinical trial
Current Status
Recruiting
Checked: October 15, 2026 at 12:00 PM UTC
| NCT Number | NCT06063850 |
| Recruiting Status | Recruiting |
| Condition | Temporal Lobe Epilepsy |
| Phase | PHASE1 |
| Target Enrollment | 12 participants |
| Active Locations | 18 sites in the US |
| Sponsor | UniQure Biopharma B.V. |
| Last Updated on CT.gov | August 24, 2026 (Aug 24, 2026) |
As of October 15, 2026: Clinical trial NCT06063850 is currently recruiting participants. This phase1 study for temporal lobe epilepsy is actively seeking new participants at 18 locations across the United States. The study is sponsored by UniQure Biopharma B.V.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06063850 is actively recruiting participants as of October 15, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 18 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06063850 was last updated Aug 24, 2026 (August 24, 2026). HelloStudys verifies this status automatically.